摘要
目的:探索地奥心血康(DAXXK)对急性心肌梗死(AMI)的疗效。方法:AMI病人89例,采用随机单盲法分为2组,DAXXK胶囊组45例,男性36例,女性9例,年龄59±s8a.采用DAXXK200mg,po,tid,共4wk。地尔硫组44例,男性34例,女性10例,年龄58±7a.采用盐酸地尔硫30mg,po,tid,共4wk。结果:DAXXK组治疗后心绞痛发作频率须静脉滴注硝酸甘油的量及镇痛药需用次数均显著低于对照组;心功能(SV,CO,LVEF,STI)改善亦显著优于对照组;心肌酶(GOT,CK,CK-MB,LDH)峰值,住院期间心力衰竭及心律失常发生率亦均显著低于对照组。结论:DAXXK是防治AMI有较好疗效的纯中药制剂。
AMI:To observe the effects of Di-ao-xin-xue-kang(DAXXK) capsule in treating acute myocardial infarction (AMI).METHODS:Eighty-nine patients with AMI were randomly assigned to 2 groups with single-blind method.DAXXK group of 45 patients(M 36, F 9; age 59± s 8 a) received DAXXK 200 mg, po,tid, for 4 wk.Diltiazem hydrochloride(Dil) group of 44 patients(M 34,F 10;age 58±7 a) received Dil,30 mg,po,tid,for 4 wk. RESULTS : DAXXK group was better than Dil group in the improvement of clinical symptoms(incidence of anginal attacks.dose of iv nitroglycerin, analgesic times),heart function tests (SV, CO, LVEF, STI). peak value of myocardium enzyme(GOT, CK CK-MB, LDH ) incidences of heart failure and arrhythmia during hospitaliZation. CONCLUSION:DAXXK is better than Dil in preventing and treating AMI.
出处
《新药与临床》
CSCD
北大核心
1995年第6期343-346,共4页